OVARIAN CLEAR CELL CARCINOMA
Clinical trials for OVARIAN CLEAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to fight rare ovarian cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new drug (QL1706) plus bevacizumab works better than standard chemotherapy for women with advanced ovarian clear cell carcinoma. About 226 women aged 18 to 74 with newly diagnosed stage IC-IV disease will be randomly assigned to receive either t…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE3 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Virus therapy may Re-Sensitize ovarian cancer to chemo
Disease control Recruiting nowThis study tests whether a cancer-killing virus (Olvi-Vec) given into the abdomen can make platinum-resistant ovarian cancer respond to chemotherapy again. About 186 women whose cancer has not responded to at least three prior treatments will receive either Olvi-Vec plus chemo an…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New combo therapy aims to tame rare ovarian cancer
Disease control Recruiting nowThis study tests whether combining two drugs, dostarlimab and LB-100, can help control ovarian clear cell carcinoma. About 21 adults with recurrent cancer will receive the treatment. The goal is to see if the combination is safe and shrinks or stabilizes the cancer.
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC